Pathophysiology of heparan sulphate: many diseases, few drugs (Q26823840)

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Domain structure of heparan sulfates from bovine organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Proteoglycans: structures and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Functions of cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulphate proteoglycans fine-tune mammalian physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Interactions between heparan sulfate and proteins-design and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Molecular diversity of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Regulated diversity of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Serglycin: a structural and functional chameleon with wide impact on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Structure and biological interactions of heparin and heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Location of N-unsubstituted glucosamine residues in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate biosynthesis: regulation and variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Inhibitory effect of the mi transcription factor encoded by the mutant mi allele on GA binding protein-mediated transcript expression in mouse mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase/n-sulfotransferase isozymes by structured 5'-untranslated regions and internal ribosome entry sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Enzyme interactions in heparan sulfate biosynthesis: uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Biosynthesis of chondroitin sulfate: interaction between xylosyltransferase and galactosyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Order out of chaos: assembly of ligand binding sites in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Degradation of heparin proteoglycan in cultured mouse mastocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Low-molecular-weight heparins: differential characterization/physical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Glycosaminoglycans and the regulation of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Sulfation patterns of glycosaminoglycans encode molecular recognition and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Interactions between heparan sulfate and proteins: the concept of specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Structure and physicochemical characterisation of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Structural basis for fibroblast growth factor receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Metabolism of macromolecular heparin in mouse neoplastic mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Processing of macromolecular heparin by heparanase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparanase affects secretory granule homeostasis of murine mast cells through degrading heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Mice deficient in Ext2 lack heparan sulfate and develop exostoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 is 6-O-sulfated but contains no N-sulfate groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Mice Deficient in Heparan Sulfate N-Deacetylase/N-Sulfotransferase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparin is essential for the storage of specific granule proteases in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Glucuronyl C5-epimerase an enzyme converting glucuronic acid to iduronic acid in heparan sulfate/heparin biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Mice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Transmembrane signaling proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

HSPG modulation of BMP signaling in fibrodysplasia ossificans progressiva cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Blood vessels as targets in tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Signaling from across the way: transactivation of VEGF receptors by HSPGs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Aspects on human amyloid forms and their fibril polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate mediates amyloid-beta internalization and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate proteoglycan 2 polymorphism in Alzheimer's disease and correlation with neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Hepatic Heparan Sulfate Proteoglycans and Endocytic Clearance of Triglyceride-Rich Lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

The biological relevance of chemokine-proteoglycan interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

The molecular basis and functional implications of chemokine interactions with heparan sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Chapter 4. Interactions of chemokines with glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Defining the interleukin-8-binding domain of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and TGF-β/Smad signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate: anchor for viral intruders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Characterization of pseudorabies virus glycoprotein C attachment to heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Binding of a N,N'-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Release of sequestered malaria parasites upon injection of a glycosaminoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Identification of Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) as the Rosetting Ligand of the Malaria Parasite P. falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Antimicrobial activities of heparin-binding peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

The role of glypican-3 in the regulation of body size and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Common variation in GPC5 is associated with acquired nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Identification of an agrin mutation that causes congenital myasthenia and affects synapse function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Prolonged labour associated with lower expression of syndecan 3 and connexin 43 in human uterine tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Low molecular weight heparin stimulates myometrial contractility and cervical remodeling in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking α-l-iduronidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Emerging therapies for neurodegenerative lysosomal storage disorders - from concept to reality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

The mucopolysaccharidoses: a success of molecular medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Significance of Heparanase in Cancer and Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparanase affects food intake and regulates energy balance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Tumor attenuation by combined heparan sulfate and polyamine depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Novel glycosaminoglycan precursors as antiamyloid agents: Part IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Surfen, a small molecule antagonist of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Deciphering the glycosaminoglycan code with the help of microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

Heparan sulfate proteoglycans in healthy and diseased systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Phenotypic and molecular characterization of a novel case of dyssegmental dysplasia, Silverman-Handmaker type

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Hepatocyte growth factor/scatter factor: a heparan sulphate-binding pleiotropic growth factor

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Amyloid-specific Heparan Sulfate from Human Liver and Spleen

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Heparan sulfate structure in mice with genetically modified heparan sulfate production

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Initial interaction of herpes simplex virus with cells is binding to heparan sulfate

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021

Reduced Sulfation of Liver Heparan Sulfate in Experimentally Diabetic Rats

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12061

7 January 2021